Your browser doesn't support javascript.
loading
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
Strati, Paolo; Lee, Seung Tae; Teegavarupu, Purnima; Karri, Anusha; Anireddy, Saswatha; Hagemeister, Fredrick B; Romaguera, Jorge; Fayad, Luis E; Rodriguez, Maria A; Samaniego, Felipe; Fowler, Nathan; Westin, Jason; Wang, Michael; Lee, Hun Ju; Pinnix, Chelsea; Gunther, Jillian R; Dabaja, Bouthaina; Feng, Lei; Davis, Richard Eric; Neelapu, Sattva S.
Afiliación
  • Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee ST; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Teegavarupu P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karri A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Anireddy S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Romaguera J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fowler N; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pinnix C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dabaja B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 94(6): E150-E153, 2019 06.
Article en En | MEDLINE | ID: mdl-30785215

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Helicobacter pylori / Linfoma de Células B de la Zona Marginal / Antibacterianos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Helicobacter pylori / Linfoma de Células B de la Zona Marginal / Antibacterianos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos